DiaMedica Therapeutics (DMAC) Change in Account Payables: 2018-2024
Historic Change in Account Payables for DiaMedica Therapeutics (DMAC) over the last 7 years, with Dec 2024 value amounting to $14,000.
- DiaMedica Therapeutics' Change in Account Payables fell 155.56% to -$130,000 in Q4 2019 from the same period last year, while for Dec 2019 it was -$301,000, marking a year-over-year decrease of 903.33%. This contributed to the annual value of $14,000 for FY2024, which is 92.71% down from last year.
- Per DiaMedica Therapeutics' latest filing, its Change in Account Payables stood at $14,000 for FY2024, which was down 92.71% from $192,000 recorded in FY2023.
- In the past 5 years, DiaMedica Therapeutics' Change in Account Payables registered a high of $917,000 during FY2020, and its lowest value of -$590,000 during FY2021.
- Its 3-year average for Change in Account Payables is $143,667, with a median of $192,000 in 2023.
- As far as peak fluctuations go, DiaMedica Therapeutics' Change in Account Payables spiked by 404.65% in 2020, and later plummeted by 164.34% in 2021.
- Yearly analysis of 5 years shows DiaMedica Therapeutics' Change in Account Payables stood at $917,000 in 2020, then plummeted by 164.34% to -$590,000 in 2021, then spiked by 138.14% to $225,000 in 2022, then declined by 14.67% to $192,000 in 2023, then tumbled by 92.71% to $14,000 in 2024.